Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherap... https://t.co/u2ZsGRpyz9
1,909 followers
19,083 followers
Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer https://t.co/uIzpBP0hQV https://t.co/eVoLOwloKN
5 followers
RT @FrontImmunol: New Research: Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in…
33,273 followers
New Research: Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer: Introduction In recent decades, the development of immunotherapy and targeted therapies has… https://t.co/